385 related articles for article (PubMed ID: 23684136)
1. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells.
Lin ZY; Chuang YH; Chuang WL
Biomed Pharmacother; 2012 Oct; 66(7):525-9. PubMed ID: 22739041
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma.
Lin ZY; Wu CC; Chuang YH; Chuang WL
Life Sci; 2013 Sep; 93(8):323-8. PubMed ID: 23871804
[TBL] [Abstract][Full Text] [Related]
4. High therapeutic concentration of prazosin up-regulates angiogenic IL6 and CCL2 genes in hepatocellular carcinoma cells.
Lin ZY; Chuang WL
Biomed Pharmacother; 2012 Dec; 66(8):583-6. PubMed ID: 23089469
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic concentrations of ascorbic acid cause diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines.
Lin ZY; Chuang WL
Biomed Pharmacother; 2010 May; 64(5):348-51. PubMed ID: 19932582
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B up-regulates angiogenic genes in hepatocellular carcinoma cell lines.
Lin ZY; Chuang WL; Chuang YH
Eur J Clin Invest; 2009 Mar; 39(3):239-45. PubMed ID: 19260954
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic concentrations of melatonin have diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines.
Lin ZY; Chuang WL
Biomed Pharmacother; 2010 Dec; 64(10):659-62. PubMed ID: 20970952
[TBL] [Abstract][Full Text] [Related]
8. Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells.
Lin ZY; Chuang WL
Biomed Pharmacother; 2012 Sep; 66(6):454-8. PubMed ID: 22681909
[TBL] [Abstract][Full Text] [Related]
9. [Dectection and analysis of miRNA expression in breast cancer-associated fibroblasts].
Zeng Z; Hu P; Tang X; Zhang H; Du Y; Wen S; Liu M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1071-5. PubMed ID: 25270211
[TBL] [Abstract][Full Text] [Related]
10. Contrary influence of clinically applied sorafenib concentrations among hepatocellular carcinoma patients.
Lin ZY; Chuang WL
Biomed Pharmacother; 2017 Feb; 86():27-31. PubMed ID: 27936391
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.
Mano Y; Yoshio S; Shoji H; Tomonari S; Aoki Y; Aoyanagi N; Okamoto T; Matsuura Y; Osawa Y; Kimura K; Yugawa K; Wang H; Oda Y; Yoshizumi T; Maehara Y; Kanto T
J Gastroenterol; 2019 Nov; 54(11):1007-1018. PubMed ID: 30941514
[TBL] [Abstract][Full Text] [Related]
12. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
[TBL] [Abstract][Full Text] [Related]
13. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature.
Herrera M; Islam AB; Herrera A; Martín P; García V; Silva J; Garcia JM; Salas C; Casal I; de Herreros AG; Bonilla F; Peña C
Clin Cancer Res; 2013 Nov; 19(21):5914-26. PubMed ID: 24052018
[TBL] [Abstract][Full Text] [Related]
14. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.
Liu J; Chen S; Wang W; Ning BF; Chen F; Shen W; Ding J; Chen W; Xie WF; Zhang X
Cancer Lett; 2016 Aug; 379(1):49-59. PubMed ID: 27216982
[TBL] [Abstract][Full Text] [Related]
16. FOXQ1/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells.
Luo Q; Wang CQ; Yang LY; Gao XM; Sun HT; Zhang Y; Zhang KL; Zhu Y; Zheng Y; Sheng YY; Lu L; Jia HL; Yu WQ; Liu J; Dong QZ; Qin LX
Cancer Lett; 2018 Mar; 417():21-34. PubMed ID: 29248714
[TBL] [Abstract][Full Text] [Related]
17. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts promote the stemness of CD24
Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B
J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864
[TBL] [Abstract][Full Text] [Related]
19. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.
Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K
J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932
[TBL] [Abstract][Full Text] [Related]
20. Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma.
Chen CF; Hsu EC; Lin KT; Tu PH; Chang HW; Lin CH; Chen YJ; Gu DL; Lin CH; Wu JY; Chen YT; Hsu MT; Jou YS
Hepatology; 2010 Nov; 52(5):1690-701. PubMed ID: 20799341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]